Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore
Prospective, Hospital-based, Multicentre Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore, 119074
- GSK Investigational Site
-
Singapore, Singapore, 169608
- GSK Investigational Site
-
Singapore, Singapore, 228510
- GSK Investigational Site
-
Singapore, Singapore, 229899
- GSK Investigational Site
-
Singapore, Singapore
- GSK Investigational Site
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- A male or female infant aged < 24months at the time of diagnosis of intussusception.
- Subject is diagnosed with definite, probable, possible, suspected intussusception during the period of at least one year beginning at study start.
- Written informed consent obtained from the parent or guardian of the subject.
Exclusion Criteria:
- A male or female infant ≥ 24 months of age at the time of intussusception diagnosis.
- The subject has had a radiographically or surgically confirmed case of intussusception prior to the current episode.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Intussusception cohort
Subjects with Intussusception
|
Reviewing screening sheets
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Occurrence of definite, probable and possible IS cases in children < 5 yrs of age
Time Frame: Average timeframe: one year
|
Average timeframe: one year
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 999910/193
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.